share_log

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

4:持股變動聲明-董事 Farley Chele Chiavacci
美股SEC公告 ·  12/21 06:10

牛牛AI助理已提取核心訊息

Farley Chele Chiavacci, associated with Conduit Pharmaceuticals, has reported a transaction scheduled for 12/18/2024. The reporting person's address is listed as 4851 Tamiami Trail North, Suite 200, Naples, FL, 34103.While the announcement provides the date of the earliest transaction, it does not disclose the nature, volume, or value of the securities involved. The relationship between the reporting person and the issuer is not specified in the provided information.It's important to note that this report is for a future transaction, as the date provided (12/18/2024) has not yet occurred. Investors should be aware that the lack of detailed transaction information limits the ability to assess the potential impact on the company's stock.
Farley Chele Chiavacci, associated with Conduit Pharmaceuticals, has reported a transaction scheduled for 12/18/2024. The reporting person's address is listed as 4851 Tamiami Trail North, Suite 200, Naples, FL, 34103.While the announcement provides the date of the earliest transaction, it does not disclose the nature, volume, or value of the securities involved. The relationship between the reporting person and the issuer is not specified in the provided information.It's important to note that this report is for a future transaction, as the date provided (12/18/2024) has not yet occurred. Investors should be aware that the lack of detailed transaction information limits the ability to assess the potential impact on the company's stock.
Farley Chele Chiavacci與Conduit Pharmaceuticals有關,已報告一筆定於2024年12月18日進行的交易。報告人地址爲佛羅里達州那不勒斯Tamiami Trail North 4851號,200套房,郵政編碼34103。儘管公告提供了最早交易的日期,但並未透露相關證券的性質、成交量或價值。報告人與發行人之間的關係在所提供的信息中未作說明。值得注意的是,此報告是關於未來交易的,因爲所提供的日期(2024年12月18日)尚未到來。投資者應注意,缺乏詳細的交易信息限制了評估對公司股票潛在影響的能力。
Farley Chele Chiavacci與Conduit Pharmaceuticals有關,已報告一筆定於2024年12月18日進行的交易。報告人地址爲佛羅里達州那不勒斯Tamiami Trail North 4851號,200套房,郵政編碼34103。儘管公告提供了最早交易的日期,但並未透露相關證券的性質、成交量或價值。報告人與發行人之間的關係在所提供的信息中未作說明。值得注意的是,此報告是關於未來交易的,因爲所提供的日期(2024年12月18日)尚未到來。投資者應注意,缺乏詳細的交易信息限制了評估對公司股票潛在影響的能力。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。